Emmausrd Competitors

CureVac (Nasdaq: CVAC) is a pioneering multinational biotech company founded in 2000 to advance the field of messenger RNA (mRNA) technology for application in human medicine. In more than two decades of developing, optimizing, and manufacturing this versatile biological molecule for medical purposes, CureVac has introduced and refined key underlying technologies that were essential to the production of mRNA vaccines against COVID-19, and is currently laying the groundwork for application of mRNA in new therapeutic areas of major unmet need. CureVac is leveraging mRNA technology, combined with advanced omics and computational tools, to design and develop off-the-shelf and personalized cancer vaccine product candidates. It also develops programs in prophylactic vaccines and in treatments that enable the human body to produce its own therapeutic proteins. Headquartered in Tübingen, Germany, CureVac also operates sites in the Netherlands, Belgium, Switzerland, and the U.S. Further information can be found at www.curevac.com.

At Puma Biotechnology, our focus is on bringing innovative therapies to patients to enhance cancer care. We are thankful to be part of the HER2+ breast cancer community and are passionate about evaluating options that may benefit patients across the breast cancer therapy spectrum.

RGI is an Independent Software Vendor, a European leader in the digital transformation of Insurers. We have been committed for more than 30 years to the Insurance industry. RGI has a wealth experience in dealing with Insurers, Bank Insurers, Agents, Brokers, independent Financial Advisors. With more than 1.200 professionals in Italy, France, DACH & Slovenia, Ireland, Africa & Middle East, we have a proven track record of successfully collaborating with more than 130 Insurers and 300 brokers across the EMEA region, supporting them on their journey to excellence. We deliver solutions and services to help Insurers achieve operational efficiency, harness the power of digital and anticipate regulatory standards. We envision, design and deliver state of the art insurance platforms and digital suites in core insurance areas, with both tailored projects as well as standard solutions for rapid roll-out.